ArticleClinical and molecular hepatology2025

Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017-2023.

Donghee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.